Brief: Orbimed Advisors Llc Reports 40.1% Stake In Theseus Pharmaceuticals Inc
24/11/2023 22:29
Nov 24 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* ORBIMED ADVISORS LLC REPORTS 40.1% STAKE IN THESEUS
PHARMACEUTICALS INC AS OF NOVEMBER 22, 2023- SEC FILING
* ORBIMED ADVISORS- ON NOV 22, ORBIMED ALONG WITH FORESITE
SUBMITTED TO BOARD OF THESEUS PHARMACEUTICALS NON-BINDING
EXPRESSION OF INTEREST LETTER
* ORBIMED ADVISORS-SENT LETTER WITH INTENT TO EXPLORE
POTENTIAL
BUYOUT OF OUTSTANDING SHARES OF THESEUS PHARMACEUTICALS, NOT
ALREADY OWNED BY ORBIMED
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7